Skip to main content
. 2017 Jun 6;7:2877. doi: 10.1038/s41598-017-03296-6

Figure 1.

Figure 1

Receiver operating characteristic curves for the semi-quantitative assessment in patients with NSCLC (a), adenocarcinoma (b) and squamous cell cancer (c) at 18F-Alfatide PET/CT.